Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis.

Xu M, Tao J, Yang Y, Tan S, Liu H, Jiang J, Zheng F, Wu B. · 2020

Read Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis. by Xu M, Tao J, Yang Y, Tan S, Liu H, Jiang J, Zheng F, Wu B. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6997394.txt.

Introduction

Xu and co-authors show that iron-driven cell death helps destroy the gut lining in ulcerative colitis. Their study appeared in Cell Death and Disease. Ulcerative colitis is a relapsing inflammation of colon and rectum, marked by pain, bleeding, and diarrhoea. The death of intestinal lining cells drives much of the damage.

Ferroptosis, a regulated death tied to iron, was switched on in lining cells from patients and from mice with colitis. Stress inside the cells' protein-folding compartment drove it. The team used mice lacking a protective factor, NF-κB p65, only in gut lining cells. Those mice suffered worse ferroptosis and worse colitis. The active form of p65 normally binds a stress switch and damps the pathway. Blocking ferroptosis, the authors propose, is a promising treatment target.

Catalog record

CREATORXu M, Tao J, Yang Y, Tan S, Liu H, Jiang J, Zheng F, Wu B.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6997394

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis By Minyi Xu, Jin Tao, Yidong Yang, Siwei Tan, Huiling Liu, Jie Jiang, Fengping Zheng, Bin Wu Published in: Cell Death & Disease DOI: 10.1038/s41419-020-2299-1 ABSTRACT Abstract Ferroptosis has recently emerged as an iron-dependent form of nonapoptotic cell death, which is also a regulated necrosis process and a response to tumor suppression. However, whether ferroptosis is involved in ulcerative colitis (UC) is unknown. The aims of this study were to investigate whether the ferroptosis is involved in UC, particularly intestinal epithelial cell (IEC) death, and to analyze the effect of the nuclear factor kappa Bp65 subunit (NF-κBp65) on ferroptosis. The gene expression of ferroptosis-related proteins was assessed in intestinal mucosal samples from human UC. The experimental model of UC was induced with dextran sulfate sodium (DSS). Ferroptosis of IECs was evaluated, the effect of NF-κBp65 on ferroptosis was analyzed by using IEC-specific NF-κBp65-deleted mice (p65IEC-KO), and the ferroptosis signaling pathway was investigated in vitro and in vivo. The results showed that ferroptosis was significantly induced in the IECs from UC patients and mice with colitis, and the ferroptosis was mediated by endoplasmic reticulum (ER) stress signaling. The specific deletion of IEC NF-κBp65 clearly upregulated ferroptosis and exacerbated colitis, and the result showed that phosphorylated-NF-κBp65 significantly inhibited ER stress signaling by directly binding eukaryotic initiation factor 2α. These data indicate that ferroptosis contributes to UC via ER stress-mediated IEC cell death, and that NF-κBp65 phosphorylation suppresses ER stress-mediated IEC ferroptosis to alleviate UC. The results suggest that ferroptosis involves in IEC death in UC, NF-κBp65 play a critical role in the ferroptotic inhibition, and ferroptosis is a potential therapeutic target for UC. Subject terms: Molecular biology, Gastroenteritis INTRODUCTION Ulcerative colitis (UC) is a chronically relapsing inflammatory disease of the colon and rectum, which is clinically characterized by abdominal pain, rectal bleeding, and diarrhea1. Although not fully understood, the etiology of UC is generally thought to be genetically based with contributions from gut microbial factors and a disordered immune response2. Recent studies have revealed the main immunological/inflammatory mechanisms of UC, and have provided new methods for modulating inflammation, but few have explored the biological changes in colonic intestinal epithelial cells (IECs). Ferroptosis has recently emerged as a newly discovered form of regulated necrosis, and it presents features that distinguish it from other kinds of cell death at the cell morphology, biochemistry, and genetics levels3,4. Shrunken mitochondria; condensed dense mitochondrial membranes; and reduced mitochondrial crista are the main morphological features of ferroptosis3,4. Iron accumulation and increased reactive oxygen species (ROS) production from lipid peroxidation play crucial roles in triggering ferroptosis3. In addition, downregulation of glutathione peroxidase 4 (GPX4), a scavenger of lipid ROS and increased mRNA levels of prostaglandin-endoperoxide synthase 2 (PTGS2) are key characteristics of ferroptotic cell death5. Although its biological function and molecular mechanism have not been thoroughly elucidated, ferroptosis has been implicated in multiple diseases5–8. Interestingly, in previous studies by different groups, the administration of iron chelator was found to significantly reduce ROS in colonic tissues of UC patients and to ameliorate clinical symptoms and improve endoscopic presentations9,10. In contrast, high dietary iron supplements exacerbated UC symptoms in both patients and murine models11,12. These findings indicated the important effects of iron and ROS on the pathogenesis of UC. However, whether iron- and ROS-triggered ferroptosis involves in UC remains unclear. Endoplasmic reticulum (ER) stress has long been considered a promoting factor in UC. Emerging evidence has shown that ER stress signaling has close cross-talk with ferroptosis. Protein kinase-like endoplasmic reticulum kinase (PERK) is a major sensor of ER stress. In response to ER stress, PERK is activated through phosphorylation, and then activates and governs the downstream signaling of the eukaryotic initiation factor 2, α subunit (eIF2α)/activating transcription factor 4 (ATF4)/C/EBP-homologous protein (CHOP) pathway13. PERK/eIF2α signaling was found to regulate the production of ROS during ferroptosis14–16. It was reported that the activation of the PERK branch facilitated whole cigarette smoke condensate-induced ferroptosis in human bronchial epithelial cells14. Results from our recent study demonstrated that ER stress signaling promotes colonic epithelial apoptosis in UC17. However, the role of ER stress-mediated ferroptosis in UC remains poorly understood and needs to be further investigated. The transcription factor nuclear factor kappa B (NF-κB) has been confirmed to exert principal function on the modulation of UC. NF-κB family is composed of five members and the activity of NF-kB is mainly initiated by the phosphorylated subunit p65. Recently, numerous studies reported that the effects of activated NF-κB are cell type-specific. NF-κB promotes cytokine and chemokine production in inflammatory cells18, whereas, it also functions in IECs to maintain physiological homeostasis and contribute to damage resistance19. Our previous study revealed that the application of the NF-κB inhibitor BAY 11-7082 enhanced epithelial apoptosis in experimental colitis20, suggesting a role for activated NF-κB in inhibiting apoptosis. Moreover, growing evidence has indicated that NF-κB is involved in the regulation of ER stress signaling and ferroptosis process21,22. However, the definite protective mechanisms of NF-κB via the regulation of ER stress-mediated ferroptosis in UC are not completely understood. In our present study, the effect and mechanism of ferroptosis in UC via the regulation of NF-κBp65/ER stress were investigated. We report first that ferroptosis is involved in the IEC cell death of UC that is mediated by ER stress signaling. Specifically, we found that phosphorylated-NF-κBp65 protects the IECs against ferroptosis by suppressing ER stress, suggesting that ferroptosis and NF-κBp65 phosphorylation are potential therapeutic targets for UC treatment. MATERIALS AND METHODS Human colonic tissue samples Colonic mucosal specimens from patients with active UC (Mayo endoscopic score ≥ 2)23 and healthy controls were collected from the Gastroenterology Department of the Third Affiliated Hospital of Sun Yat-Sen University. Written informed consent was signed by each study participant. The acquisition of these samples was approved by the Clinical Research Ethics Committee of The Third Affiliated Hospital of Sun Yat-Sen University ([2018] 02-409-01). Microarray experiment Three paired colonic mucosal samples from colitis patients and control individuals were collected. Total RNA from each sample was extracted and reverse transcribed into cDNA. The cDNA was then processed for gene expression microanalysis as previously described24. The Gene Expression Omnibus (GEO) accession number from NCBI is GSE134025. Animal experiments All animal experiments in this study were conducted with the approval of the Institutional Animal Care and Use Committee at Sun Yat-Sen University. All mice involved had a C57BL/6 gene background. Wild-type mice were obtained from the Laboratory Animal Center of Guangdong Province. Mice carrying the loxP-flanked NF-κBp65 allele [NF-κBp65flox/flox] were precious gifts from Dr. Jianping Ye [Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA]. Villin-cre transgenic mice were purchased from The Jackson Laboratory. Mice with IEC-specific NF-κBp65-deletion [p65IEC-KO] were generated by breeding NF-κBp65flox/flox mice with villin-cre transgenic mice, and the NF-κBp65flox/flox littermates were used as wild-type (WT) mice. All mice were housed in rooms under controlled condition, with room temperature and with 50% humidity and 12-hour light–dark cycles. All mice with age- and sex-matched between 6 and 8 weeks of age were assigned randomly to groups. To induce experimental colitis, the mice were challenged with 3% dextran sulfate sodium (DSS; MP Biomedicals, LLC, Solon, OH) in drinking water for 7 days.

Read the complete text